2025 Market Reports Update: Market Size Forecasts to 2034, Key Trends, Leading Players, and Top Regions – Get Ahead of the Competition Today!
What Are the Primary Drivers Supporting the Market Growth of theGastrointestinal Bleeding Treatment Devices Market?
The increase in cases of upper gastrointestinal bleeding is expected to stimulate the expansion of the gastrointestinal bleeding treatment devices market throughout the projection period. Upper gastrointestinal (GI) bleeding, which occurs in the esophagus, stomach, or upper segment of the small intestine, can be induced by various circumstances including peptic ulcers, esophagitis, enteritis, gastritis, cancer, among others. For example, based on the National Institute for Health and Care Excellence data in the UK, the occurrence rate of acute upper GI bleeding spans between 84-172 per 100,000 population annually. Moreover, a research published in the National Library of Medicine – National Institutes of Health in 2023 reported that in-hospital death rates for upper GI bleeds are approximately 10%, a figure that remains steady for up to a month post-hospitalization for GI bleed. Over an extended period, the mortality rates from all causes almost reach 37% three years post-admission.
Get Your Free Sample Report Now – Explore Exclusive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=5307&type=smp
#What is the Growth Potential of the Gastrointestinal Bleeding Treatment Devices Market, and How Will It Perform by 2034?
In recent times, there has been a notable expansion in the market size of gastrointestinal bleeding treatment devices. The market is forecasted to rise from a worth of $0.87 billion in 2024 to an estimated $0.93 billion in 2025, marking a compound annual growth rate (CAGR) of 6.1%. The growth observed during the historic period can be linked to factors such as an aging population, lifestyle influences, developments in healthcare infrastructure, the prevalence of gastrointestinal disorders, and advancements in endoscopy techniques.
The market for gastrointestinal bleeding treatment devices is predicted to witness robust expansion in the coming years, reaching a valuation of $1.3 billion by 2029, at a compound annual growth rate (CAGR) of 8.9%. This growth anticipated during the forecast period can be credited to factors such as patient-focused care, alterations in regulations, the adoption of telemedicine and remote consultations, the rise in gastrointestinal disorders, and investments in healthcare. Innovations influencing this trend include non-invasive diagnostic technologies, precision medicine, remote monitoring and telehealth developments, and the implementation of artificial intelligence and machine learning.
You can Directly Purchase the Report Here:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=5307
What Are the Latest Innovations Influencing the Gastrointestinal Bleeding Treatment Devices Market?
Key businesses in the market for equipment used in treating gastrointestinal bleeding are forging ahead with the development of innovative solutions such as the EVIS X1 endoscopy system. This is aimed at increasing diagnostic precision, enhancing patient results, and optimizing clinical procedures. The EVIS X1 is an augmented endoscopic imaging platform designed to enhance diagnostic and therapeutic intervention across numerous fields of medicine, notably gastroenterology, pulmonology, and urology. For instance, in November 2023, Olympus Corporation, a leading Japanese company in medical and surgical technologies, released its advanced next-generation EVIS X1 endoscopy system. This new iteration of the EVIS X1, a progressive breakthrough in endoscopic imaging technology, is designed to enhance diagnostic potential and procedural efficiency, and provide better clinical outcomes. Further improvements to the original EVIS X1 system include enhanced imaging techniques, user-centered interfaces, and artificial intelligence (AI) backing, adapted to serve a broad array of medical applications, with a primary focus on gastroenterology and pulmonology.
Who Are the Major Industry Players Accelerating Growth in theGastrointestinal Bleeding Treatment Devices Market?
Major companies operating in the gastrointestinal bleeding treatment devices market include CONMED Corporation, Boston Scientific Corporation, Ovesco Endoscopy AG, Olympus Corporation, Cook Medical, Erbe Elektromedizin GmbH, Steris plc., Medtronic, Johnson & Johnson, Abbott Laboratories, Fujifilm Holdings Corporation, Pentax Medical, Merit Medical Systems, Teleflex Incorporated, AngioDynamics, BTG International Ltd., Medline Industries Inc. Smiths Medical, Terumo Corporation, Nipro Corporation, ConvaTec Group PLC, Coloplast A/S, Hollister Incorporated, Wellspect HealthCare, C. R. Bard Inc., EndoChoice Holdings Inc., GI Supply Inc., Hemostasis LLC
Order Your Report Now For A Swift Delivery:
Which Primary Segments of the Gastrointestinal Bleeding Treatment Devices Market Are Driving Growth and Industry Transformations?
The gastrointestinal bleeding treatment devices market covered in this report is segmented –
1) By Product: Endoscopic Thermal Devices, Other Products
2) By GI Tract Division: Upper GI Tract, Lower GI Tract
3) By End User: Hospitals Or Clinics, Ambulatory Surgical Centers, Other End-users
Subsegments:
1) By Endoscopic Thermal Devices: Radiofrequency Ablation Devices, Laser Therapy Devices, Coagulation Devices
2) By Other Products: Hemostatic Clips, Injection Devices, Mechanical Hemostatic Devices
Gain Exclusive Market Insights—Customize Your Research Report Today for Fast Delivery!
https://www.thebusinessresearchcompany.com/customise?id=5307&type=smp
Which Regions Are Key Players in the Growth of the #What Are the Primary Drivers Supporting the Market Growth of theGastrointestinal Bleeding Treatment Devices Market?# Market?
North America was the largest region in the gastrointestinal bleeding treatment devices market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the gastrointestinal bleeding treatment devices market report include Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
Browse Through More Reports Similar to the Gobal Gastrointestinal Bleeding Treatment Devices Maret 2025, By The Business Research Company:
Blood And Blood Components Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/blood-and-blood-components-global-market-report
Stem Cell/Cord Blood Banking Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/stem-cell-cord-blood-banking-global-market-report
Blood Glucose Meters Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/blood-glucose-meters-global-market-report
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Contact us at:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Found this article helpful? Share it on:
